Rapamycin in Relapsed Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This is a research study designed to look at the biological effects of two drugs on leukemia
cells. In this study, we are comparing the effects of drugs called corticosteroids when used
alone or with another drug called rapamycin. Rapamycin is a drug that prevents the body's
immune system from working normally. It has been used for many years after kidney transplants
to prevent rejection of the organ. Recent work suggests that rapamycin may also help treat
leukemia and other cancers.
Phase:
Phase 1
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Boston Children's Hospital Boston Children’s Hospital Brigham and Women's Hospital National Cancer Institute (NCI)